These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The promise and challenge of therapeutic genome editing. Doudna JA Nature; 2020 Feb; 578(7794):229-236. PubMed ID: 32051598 [TBL] [Abstract][Full Text] [Related]
3. National Academies relax stance on germline edits. Sheridan C Nat Biotechnol; 2017 Apr; 35(4):295-296. PubMed ID: 28398320 [No Abstract] [Full Text] [Related]
4. Ethics of Human Genome Editing. Coller BS Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366 [TBL] [Abstract][Full Text] [Related]
5. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment. Jiang C; Meng L; Yang B; Luo X Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788 [TBL] [Abstract][Full Text] [Related]
6. CRISPR gene editing in human embryos wreaks chromosomal mayhem. Ledford H Nature; 2020 Jul; 583(7814):17-18. PubMed ID: 32606465 [No Abstract] [Full Text] [Related]
7. First in vivo human genome editing trial. Nat Biotechnol; 2018 Jan; 36(1):5. PubMed ID: 29319687 [No Abstract] [Full Text] [Related]
8. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia? Burbery R J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632 [TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine. Jacinto FV; Link W; Ferreira BI J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600 [TBL] [Abstract][Full Text] [Related]
12. What Do We Really Think About Human Germline Genome Editing, and What Does It Mean for Medicine? Musunuru K; Lagor WR; Miano JM Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 28974517 [TBL] [Abstract][Full Text] [Related]
13. Target Discovery for Precision Medicine Using High-Throughput Genome Engineering. Guo X; Chitale P; Sanjana NE Adv Exp Med Biol; 2017; 1016():123-145. PubMed ID: 29130157 [TBL] [Abstract][Full Text] [Related]
14. Making sense of heritable human genome editing: Scientific and ethical considerations. Greenfield A Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039 [TBL] [Abstract][Full Text] [Related]
15. Development and application of CRISPR/Cas9 technologies in genomic editing. Zhang C; Quan R; Wang J Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822 [TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Therapeutic Genome Editing in China. Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996 [TBL] [Abstract][Full Text] [Related]
17. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells. Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565 [TBL] [Abstract][Full Text] [Related]
18. The ethics of creating genetically modified children using genome editing. Ishii T Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275 [TBL] [Abstract][Full Text] [Related]
19. [A new milestone in human embryo editing]. Jordan B Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733 [TBL] [Abstract][Full Text] [Related]
20. Procreative Non-Maleficence: A South African Human Rights Perspective on Heritable Human Genome Editing. Thaldar D; Shozi B CRISPR J; 2020 Feb; 3(1):32-36. PubMed ID: 32091250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]